Cutler Group’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,800
Closed -$3K 6341
2021
Q4
$3K Buy
+3,800
New +$24.2K ﹤0.01% 4625

Other funds holding LHDX

Cutler Group's LHDX Position: Q3 2022 in Review

Cutler Group sold out of Lucira Health, Inc. Common Stock (LHDX) in Q3 2022, closing a stake of 3,515 shares — an estimated $6K sold.

Cutler Group first reported a position in LHDX in Q3 2021 and held it in 4 quarters. The position peaked at $243K in Q4 2021. 28 funds tracked by Wall St. Rank hold LHDX as of Q3 2022.

  • Cutler Group reported no remaining Lucira Health, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 3,515 Lucira Health, Inc. Common Stock shares in Q3 2022, an estimated $6K.
  • Cutler Group first reported a position in Lucira Health, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Cutler Group's Lucira Health, Inc. Common Stock position peaked at $243K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.